Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion
- 1 May 1992
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 118 (5) , 371-376
- https://doi.org/10.1007/bf01294442
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cytoreduction and sequential resection: A hope for unresectable primary liver cancerJournal of Surgical Oncology, 1991
- Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodiesInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Radioimmunodetection of Tumors with Monoclonal Antiplacental Ferritin Antibody: Preliminary ResultsOncology, 1989
- Dynamics of antibody transport and internalizationInternational Journal of Cancer, 1988
- Radioimmunotherapy of cancer: clinical studies and limiting factorsCancer Treatment Reviews, 1987
- Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.Proceedings of the National Academy of Sciences, 1987
- The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on their combined effects on a murine squamous cell carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusionInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978
- RADIOLABELED ANTIBODIESAnnals of the New York Academy of Sciences, 1957